Published Erratum Antiviral therapy. 2017;22(5):459-460. doi: 10.3851/IMP3192 Q32.32025

Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study

多拉特格韦/阿巴卡韦/拉米夫定与当前抗逆转录病毒药物疗法(STRIIVING)：一项针对病毒学上抑制的患者、为期48周的随机、非劣效性、开放标签的III期试验 翻译改进

作者单位 +展开

DOI: 10.3851/IMP3192 PMID: 28901945

摘要 中英对照阅读

Copyright © Antiviral therapy. 中文内容为AI机器翻译，仅供参考！

相关内容

• Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study

  拉伏替尼/阿巴卡韦/拉米夫定与当前疗法在病毒抑制患者中的疗效比较（STRIIVING研究）：一项为期48周的随机、非劣效性、开放标签III期试验

  Benoît Trottier et al.

  Antiviral therapy. 2017;22(4):295-305.

• Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools

  紫外分光光度法结合化学计量学工具分析多替拉韦、拉米夫定和阿巴卡韦三者混合的抗逆转录病毒疗法药物成分

  Ahmed Serag et al.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2022 Jan 5:264:120334.

• Dolutegravir plus lamivudine dual therapy - a new option for initial antiretroviral therapy

  多替拉韦联合拉米夫定双联治疗-初始抗逆转录病毒治疗的新选择

  M Fida

  Drugs of today (Barcelona, Spain : 1998). 2019 May;55(5):297-304.

• Drug-Drug Interaction between the Direct-Acting Antiviral Regimen of Ombitasvir-Paritaprevir-Ritonavir plus Dasabuvir and the HIV Antiretroviral Agent Dolutegravir or Abacavir plus Lamivudine

  奥比塔斯维-帕利他韦-利托那韦联合达萨布韦与治疗艾滋病的抗逆转录病毒药物多替拉韦或阿巴卡韦和拉米夫定之间相互作用的研究

  Amit Khatri et al.

  Antimicrobial agents and chemotherapy. 2016 Sep 23;60(10):6244-51.

• Bioequivalence of a dolutegravir, abacavir, and lamivudine fixed-dose combination tablet and the effect of food

  多替拉韦、阿巴卡韦和拉米夫定复方制剂的生物等效性及其受食物影响的情况

  Stephen Weller et al.

  Journal of acquired immune deficiency syndromes (1999). 2014 Aug 1;66(4):393-8.

• Dolutegravir, abacavir and lamivudine as HIV therapy

  多替拉韦、阿巴卡韦和拉米夫定作为治疗艾滋病的药物

  Jose Vicente Fernandez-Montero et al.

  Expert opinion on pharmacotherapy. 2014 May;15(7):1051-7.

• Evaluation of Subclinical Left Ventricular Dysfunction in HIV Patients Receiving Abacavir, Dolutegravir, and Lamivudine Therapy with Novel Tissue Doppler Imaging Techniques

  接受阿巴卡韦、多立韦瑞和拉米夫定治疗的HIV患者亚临床左心室功能障碍的新组织多普勒成像技术评估

  Dogac Oksen et al.

  Journal of clinical medicine. 2025 Feb 25;14(5):1534.

• Dolutegravir plus abacavir/lamivudine works in adolescents, but size matters

  多替拉韦搭配阿巴卡韦/拉米夫定对青少年有效，但疗效和体重有关

  Ferran Bossacoma Busquets et al.

  The Journal of antimicrobial chemotherapy. 2017 Oct 1;72(10):2958-2960.